Lenacapavir Demonstrates Viral Suppression Ability In 80% Of Heavily-Pretreated Patients With HIV With Multi-Drug Resistance, Findings Show

MedPage Today (7/21, Walker) reports, “More than 80% of heavily treatment-experienced HIV patients with multi-drug resistance who received long-acting subcutaneous lenacapavir along with an optimized background regimen experienced viral suppression at wee...